Sponsored by AseBio
23 May 202320 years of BIOSPAIN – The evolution of an international biotech event
This year marks the 20th anniversary of BIOSPAIN, an international meeting showcasing new developments in biotech and also a benchmark…
Ute Boronowsky
About
Ute Boronowsky obtained a PhD in plant biochemistry at the Ruhr-University Bochum in 1999. After her postdoc at UCLA, she moved to the biotech industry and worked in various sales and marketing positions. Since 2015, she works as a freelance science and marketing writer, translator, and journalist.
Articles by Ute Boronowsky
Sponsored by PL BioScience
25 Apr 2023Becoming human: GMP-compliant supplements for cell therapy
Media additives, or supplements, are indispensable for cell growth and vitality, as they deliver vitamins, energy sources, and various other…
Sponsored by B2B - Breast2Bone
21 Feb 2023From breast to bone: Refining metastasis drug discovery with a novel organ-on-a-chip device
Understanding invasive cancer progression and metastasis formation are among the core open questions in cancer research. However, the limitations of…
Sponsored by Merck
14 Feb 2023How efficient lab inventory management can become a driver for success
Lab inventory management is often not the first priority of biotech companies trying to stay ahead in a competitive environment.…
ADVERTISEMENT
Sponsored by LINK Medical
26 Jan 2023How clinical trials benefit from decentralized solutions: A Nordic case study
Digitization is changing the way clinical trials are conducted. Spurred by the pandemic, decentralized clinical trials are on the rise,…
Sponsored by ACROBiosystems
23 Dec 2022Transforming customer journeys, one step at a time: An interview with Mike Chen, CEO of ACROBiosystems
Customer journeys are very individual as each customer has different needs, and each manufacturer has its own philosophy regarding product…
Sponsored by Precision for Medicine
26 Jul 2022Using the full potential of circulating tumor cells for oncology clinical trials
Circulating tumor cell counts are powerful prognostic factors for cancer patients. Recent research has found that they can be quite…
Sponsored by Merck
21 Jul 2022You need to reach market readiness? What now?
Advancing a drug to market readiness is a major milestone. After successfully completing clinical studies, manufacturing and analytical processes must…
Sponsored by Merck
23 Jun 2022How a global network accelerated the development of a virus-like particle vaccine against Covid-19
Vaccines are among the most effective ways to improve and protect human health. Whereas vaccines in Europe and North America…
Sponsored by Biovian
7 Jun 2022Gene therapy: can CDMOs solve the manufacturing bottleneck?
The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies, are playing an increasing role…
ADVERTISEMENT
Sponsored by Precision for Medicine
19 Apr 2022How a Berlin-Based Biotech Pushes the Limits of Immune Cell Monitoring
Immune cell monitoring is imperative for almost any clinical study. The problem: Current procedures require viable cells, a demand often…
Sponsored by Link Medical
4 Jan 2022Why Biostatisticians are Essential for Successful Clinical Trial Management
The role of biostatisticians goes far beyond analyzing data at the end of a clinical study. Instead, they should be…
Sponsored by Charles River Laboratories
21 Dec 2021Using Cell Microarrays to Detect Off-Target Effects in Drug Development
A primary concern in drug development is the binding of drugs to targets they are not supposed to bind to.…
Sponsored by Vetter
6 Jul 2021How a CDMO Alliance Sets New Standards for Drug Development and Commercialization
To speed up drug development and commercialization, most biotechs partner with contract development and manufacturing organizations (CDMOs). Often though, they…
Sponsored by AseBio
8 Jun 2021Why BIOSPAIN 2021 Could Become a Reunion Event for the Biotech Industry
Partnering events are unique opportunities for biotechs to present their projects to potential investors and secure funding. These meetings are…
Sponsored by LINK Medical
6 Apr 2021Data Management: Taking the Right Turn at the Clinical Trial Crossroads
The success of a new drug depends on much more than its efficacy and safety or the ingenuity of its…
ADVERTISEMENT
Sponsored by Merck
17 Mar 2021Afraid of Tech Transfer? There’s No Need!
Tech transfer appears on the agenda of almost every biotech company. After identifying a suitable molecule, biotechs need support from…
Sponsored by Precision for Medicine
2 Feb 2021Sample Processing & Management – Hidden Success Factors in Clinical Trials
Standardized, carefully managed samples are indispensable for the success of any clinical study. Still, sample processing and management receive little…
Sponsored by Clarivate
11 Nov 2020Why Biotech Fundraising is at a Record High
In 2020, fundraising seems like an even bigger challenge than before. The biotech industry, however, is seeing a record high…
Sponsored by Merck
7 Sep 2020Bioburden Detection: The Hidden Bottleneck in Drug Manufacturing
Bioburden detection is one of the quality control measures required to ensure drug safety – and a possible bottleneck for…